It will play a key role in the U.S. “All of Us” effort to advance individualized medicine.
Author’s archive
IPO documents reveal potential of clinic’s collaboration with Evelo Biosciences.
Its Office of Technology and Commercialization is up for a GUV Award in London.
Powered by the Mayo Clinic’s AI, research claims it can read blood potassium with a touch.
Medicool Technologies is looking to halt atrial fibrillations painlessly with a new, novel implant.
Method uses newly-discovered molecular targets to make deadly tumors more vulnerable.
San Francisco anti-aging firm seeks $85 million for clinical trials using Mayo intelligence.
Use of ‘liquid biopsies’ to track disease progression found to be feasible.
The shuttered 1920s theater will host ‘interim uses’ with a $1 million infusion.
Thaddeus Medical is in line for $50K, while Hunhu Medical declared a loss in its report to the city.
Their startup makes tool for fast-growing ‘mechanical thrombectomy’ procedures.
The Rochester firm will hire up to 30 new workers as it completes a new headquarters build-out.
The incubator grad said it was making “remarkable progress” with its carpel tunnel surgery device.
The follow-on investment in Helix's $200 million Series B round furthers Mayo’s goal to ‘democratize’ patient knowledge.
A ‘dipstick’ test for urinary tract infections could one day be available in drugstores.
Massachusetts-based Hologic Inc. landed the U.S. rights for the University of Minnesota's 'Dexalytics' athletic performance software.
Sonex Health of Rochester and Oculogics of Minneapolis land initial venture backing.
The mixed public-private effort with Vaccinex is aiming to bring about a treatment for intractable osteosarcoma.